Effect of clofarabine and fludarabine exposure on outcome after pediatric allogeneic hematopoietic cell transplantation
- PMID: 40548196
- PMCID: PMC12182839
- DOI: 10.1016/j.bneo.2024.100030
Effect of clofarabine and fludarabine exposure on outcome after pediatric allogeneic hematopoietic cell transplantation
Conflict of interest statement
Conflict-of-interest disclosure: J.J.B. reports consulting for Sanofi, Sobi, Merck, Immunosoft, SmartImmune, and Advanced Clinical. The remaining authors declare no competing financial interests.
Similar articles
-
Population Pharmacokinetics of Clofarabine as Part of Pretransplantation Conditioning in Pediatric Subjects before Hematopoietic Cell Transplantation.Biol Blood Marrow Transplant. 2019 Aug;25(8):1603-1610. doi: 10.1016/j.bbmt.2019.04.017. Epub 2019 Apr 17. Biol Blood Marrow Transplant. 2019. PMID: 31002993 Free PMC article. Clinical Trial.
-
Clofarabine-based chemotherapy as a bridge to transplant in the setting of refractory or relapsed acute myeloid leukemia, after at least one previous unsuccessful salvage treatment containing fludarabine: a single institution experience.Int J Hematol. 2017 Jun;105(6):769-776. doi: 10.1007/s12185-017-2198-0. Epub 2017 Feb 20. Int J Hematol. 2017. PMID: 28220349
-
Clofarabine versus fludarabine-based reduced-intensity conditioning regimen prior to allogeneic transplantation in adults with AML/MDS.Cancer Med. 2016 Nov;5(11):3068-3076. doi: 10.1002/cam4.880. Epub 2016 Oct 17. Cancer Med. 2016. PMID: 27748046 Free PMC article.
-
Rational Alternatives to Fludarabine and Cyclophosphamide-Based Pre-CAR Lymphodepleting Regimens in the Pediatric and Young Adult B-ALL Setting.Curr Oncol Rep. 2023 Aug;25(8):841-846. doi: 10.1007/s11912-023-01404-6. Epub 2023 Apr 26. Curr Oncol Rep. 2023. PMID: 37099243 Review.
-
Reduced intensity is preferred over myeloablative conditioning allogeneic HCT in chronic lymphocytic leukemia whenever indicated: A systematic review/meta-analysis.Hematol Oncol Stem Cell Ther. 2018 Jun;11(2):53-64. doi: 10.1016/j.hemonc.2017.11.001. Epub 2017 Nov 26. Hematol Oncol Stem Cell Ther. 2018. PMID: 29197550
References
-
- Alatrash G, Thall PF, Valdez BC, et al. Long-term outcomes after treatment with clofarabine ± fludarabine with once-daily intravenous busulfan as pretransplant conditioning therapy for advanced myeloid leukemia and myelodysplastic syndrome. Biol Blood Marrow Transplant. 2016;22(10):1792–1800. - PMC - PubMed
-
- Freycon F, Casagranda L, Trombert-Paviot B. The impact of severe late-effects after 12 Gy fractionated total body irradiation and allogeneic stem cell transplantation for childhood leukemia (1988-2010) Pediatr Hematol Oncol. 2019;36(2):86–102. - PubMed
LinkOut - more resources
Full Text Sources